Document is current
Any future updates will be listed below
-
Authors
Cierna, Zuzana
Miskovska, Vera
Roska, Jan
Jurkovicova, Dana
Pulzova, Lucia Borszekova
Sestakova, Zuzana
Hurbanova, Lenka
Machalekova, Katarina
Chovanec, Michal
Rejlekova, Katarina
Svetlovska, Daniela
Kalavska, Katarina
Kajo, Karol
Babal, Pavel
Mardiak, Jozef
Ward, Thomas A.
Mego, Michal
Chovanec, Miroslav http://orcid.org/0000-0001-9120-5084
-
Funding
Funding for this research was provided by:
VEGA Grant Agency of the Slovak Republic (2/0108/17, 2/0053/19, 1/0043/18)
Slovak Research and Development Agency (APVV-17-0384, APVV-0016-11, APVV-15-0086)
Ministry of Health of the Slovak Republic (2019/57-BMCSAV-1)
- License Information
-
More Information
Article History
Received: 13 February 2019
Accepted: 23 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: This study (IZLO 1) was approved by the Ethics Committee of the National Cancer Institute on the 2nd of February 2010, and waiver of informed consent was granted according to the Biomedical Research Act No. 576/2004 Z.z. of the Slovak Republic. None of the cell lines required ethics approval for its use.
: Not applicable.
: All of the authors declare that they have no conflict of interest.
